Monthly Archives: April 2016

Biothera Pharmaceuticals Presents New Cancer Immunotherapy Research at the 2016 American Association for Cancer Research (AACR) Annual Meeting

EAGAN, MN — April 18, 2016 — Biothera Pharmaceuticals, Inc. today announced research providing new insights into the ability of the Company’s Phase 2 cancer immunotherapy to coordinate innate and adaptive immune responses and enhance the effectiveness of combination therapies. The findings were presented today at the AACR annual meeting, which is taking place in New Orleans, LA, April 16-20, 2016. The company is presenting...

Read More


Biothera Pharmaceuticals to Present at Third Annual Jefferies Immuno-Oncology Summit

EAGAN, MN — April 4, 2016 — Biothera Pharmaceuticals, Inc. today announced that Barry Labinger, Chief Executive Officer, will present at the 3rd Annual Jefferies Immuno-Oncology Summit on Friday, April 8, 2016 at 1:15p.m. Eastern Time in Boston, Mass. Mr. Labinger will provide an overview of Biothera and its clinical development plans in oncology. About Biothera Pharmaceuticals, Inc.Biothera Pharmaceuticals is a privately held biotechnology company...

Read More